Weight loss drugs like Ozempic deliver more health benefits than expected.

Researchers found that GLP-1 receptor agonists (GLP-1RAs) significantly reduce the risk of several blood cancers in type 2 ...

The federal government has spent $6.2 billion on research and development for weight-loss drugs. Now, thanks to Big Pharma ...

GLP-1 receptor agonists show promise in treating alcohol addiction by modulating reward pathways and reducing cravings, offering a novel therapeutic approach.

The first line of pharmacological treatment for schizophrenia is antipsychotic medication. However, antipsychotic medications are ineffective in more than 30% of people with the disorder. This is ...

In jails and prisons, drugs are still available, effective treatment is rare, and overdoses occur. People can also cycle in and out of jail, ending up back on the street without meaningful care or ...

mixing or altering drug ingredients − have prospered amid shortages of the class of weight-loss medications, called GLP-1 (glucagon-like peptide-1) receptor agonists. Hims & Hers, which ...

False Belief 1: Drug experimentation is normal for teens and shouldn’t alarm parents. Drug use and experimentation among teens often is ignored by many—even parents, who then may be unaware ...

covered in the analyst's report "Glucagon-Like Peptide-1 Receptor (GLP-1R) Agonists in Type 2 Diabetes and Obesity: Seven -Market Drug Forecast and Market Analysis", published in April 2024.

Between 2025 and 2026, the country is set to witness the launch of major obesity drugs. These drugs belong to a class known as glucagon-like peptide receptor agonists (GLP-1RAs), which mimic a natural ...

Popular drugs for diabetes and weight loss could have an unexpected side effect. Glucagon-like peptide 1 (GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity ...

the direct-to-consumer telehealth company promotes its ability to prescribe and dispense glucagon-like peptide-1 (GLP-1) receptor agonist medications to patients. The commercials include claims about ...